<?xml version="1.0" encoding="UTF-8"?>
<Rows>
 <Row><RID>00000001</RID> <date_of_birth>1951</date_of_birth> <sex>F</sex> <age_diagnosis> 59.0</age_diagnosis> <age_operration> 60.0</age_operration> <age_currently> 61.0</age_currently>   <height> 150.2</height> <weight> 53.55</weight> <BMI> 23.8</BMI> <BSA> 1.49</BSA> <diagnosis_name>C189.000.03</diagnosis_name> <diagnosis_date>20101013</diagnosis_date> <diagnosis_date_1>20101013</diagnosis_date_1> <diagnosis_date_2>20101016</diagnosis_date_2> <date_preop_colonoscopy>20120502</date_preop_colonoscopy> <number_of_tumors>1</number_of_tumors> <tumor_size> 8.8</tumor_size> <tumor_location> 3.0</tumor_location>  <biopsy_results>7</biopsy_results> <occlusion>0</occlusion> <CT_date>20120502</CT_date>    <PETCT_date>20120510</PETCT_date> <PETCT_Result>[FINDING]
PROCEDURE:
검사 직전에 측정한 환자의 혈당치는 97 mg&#47;dl, 신장 150 cm, 체중 62 kg 이었고, F-18 FDG 13.2 mCi를 Lt. forearm 에 정맥 주사하고 1 시간 후에 orbito-meatal line에서 proximal thigh까지의 torso 영상을 얻었음.

CLINICAL INFORMATION:
1. Colon cancer.
2. Bx: Hepatic flexure mass (adenocarcinoma, MD to PD), 10&#47;10&#47;09. 
3. CTx: (1) Palliative mFOLFOX #10, 10&#47;10&#47;14~11&#47;04&#47;19; (2) LV&#47;5FU #10, 11&#47;05&#47;10~11&#47;12&#47;10; (3) mFOLFOX #6, 11&#47;12&#47;30~12&#47;04&#47;28.
4. Restaging.

FINDINGS:
2010년 10월 11일 시행한 PET&#47;CT와 비교 판독하였음. (SUVmean of the liver: 1.6 --&gt;2.3).
Hepatic flexure of colon의 intense FDG uptake은 intensity가 약간 증가함 (SUVmax: 11.4 -&gt; 17.4, T&#47;L ratio: 7.1 -&gt; 7.6, 6.2 % 증가). 

Aortocaval area의 focal FDG uptakes는 수가 증가함 (2.6-&gt;3.3, T&#47;L ratio: 1.6-&gt;1.4).
Lt. supracalvicular area에 보이던 conglomerated FDG uptakes는 extent는 감소하였으나 intensity는 큰 변화 없음 (6.1-&gt;7.4, T&#47;L ratio: 2.9-&gt;3.1).
Periportal area의 focal FDG uptake은 뚜렷하지 않음.
Pericolic, portocaval, retrocaval, paraaortic space, mesentery에 보이던 other focal FDG uptakes는 전반적으로 extent와 intensity가 감소함. 

Rt. internal jugular chain에 보이던 focal FDG uptake은 소실됨. 

Rt. pleura와 LUL의 metastatic nodule은 변화 없음. 

그 외 특이 소견 없음.
[CONCLUSION]
1. Intensely FDG-avid malignant tumor in hepatic flexure of colon - essentially stable. 
2. Metastatic lymphadenopathies in 
      (1) Aortocaval area - increased number.
      (2) Lt. supraclavicular area - decreased extent but stable metabolic response. 
      (3) Periportal area, pericolic, portocaval, retrocaval, paraaortic space, mesentery - essentially regressed. 
3. Metastatic nodules in Rt. pleura and LUL - unchanged.
4. Reactive LN in Rt. internal jugular chain - resolved.</PETCT_Result> <CEA>13.33</CEA> <CA19-9>27.50</CA19-9> <pT_stage>20120511</pT_stage> <operation_date> 2.0</operation_date> <op_approach> 2.0</op_approach> <op_radicality>1</op_radicality>  <op_vessel_ligation> 5.0</op_vessel_ligation>   <sN_stage> 9.0</sN_stage> <sM_stage> 1.0</sM_stage> <ascites> 0.0</ascites> <cytology> 195.0</cytology> <operation_time>200</operation_time> <blood_loss>20120511</blood_loss> <pathology_report_date>1</pathology_report_date> <pathology_number_of_tumor> 8.8</pathology_number_of_tumor> <tumor_size_long_diameter> 5.5</tumor_size_long_diameter> <tumor_size_short_diameter> 3.0</tumor_size_short_diameter>    <resection_margin_circular> 30.0</resection_margin_circular>  <submucosa_invasion_depth> 30.0</submucosa_invasion_depth> <pN_stage> 21.0</pN_stage> <pM_stage>0</pM_stage> <metastatic_lymphnode>38</metastatic_lymphnode> <retrieved_lymphnode>4</retrieved_lymphnode>  <lymphatic_invasion> 1.0</lymphatic_invasion>  <neural_invasion> 0.0</neural_invasion> </Row>
 <Row><RID>00000002</RID> <date_of_birth>1936</date_of_birth> <sex>F</sex> <age_diagnosis> 82.0</age_diagnosis> <age_operration> 83.0</age_operration> <age_currently> 84.0</age_currently>   <height> 153.0</height> <weight> 58.0</weight> <BMI> 24.7</BMI> <BSA> 1.57</BSA> <diagnosis_name>C20.000.02</diagnosis_name> <diagnosis_date>20180808</diagnosis_date> <diagnosis_date_1>20180808</diagnosis_date_1> <diagnosis_date_2>20180808</diagnosis_date_2> <date_preop_colonoscopy>20180802</date_preop_colonoscopy>     <biopsy_results>7</biopsy_results> <occlusion>0</occlusion> <CT_date>20181207</CT_date>      <CEA>2.51</CEA> <CA19-9>5.05</CA19-9> <pT_stage>20190610</pT_stage> <operation_date> 4.0</operation_date> <op_approach> 4.0</op_approach> <op_radicality>99</op_radicality>  <op_vessel_ligation> 11.0</op_vessel_ligation>   <sN_stage> 9.0</sN_stage> <sM_stage> 0.0</sM_stage> <ascites> 0.0</ascites>                      </Row>
</Rows>